Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Amicus Releases More Impressive Pompe Disease Data at WORLDSymposium

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The company presented a late-breaker poster and corresponding oral presentation at the conference. Source: BioSpace

Continue ReadingAmicus Releases More Impressive Pompe Disease Data at WORLDSymposium

Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The FDA approved Gilead's triple combination treatment for HIV, Biktarvy. Source: BioSpace

Continue ReadingGilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy

Interview Insider: Tips on How to Get Hired at Vertex Pharmaceuticals

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Here is some insight on what Vertex may be looking for in their employees. Source: BioSpace

Continue ReadingInterview Insider: Tips on How to Get Hired at Vertex Pharmaceuticals

FDA Publishes Guidance on Microbiology Data for Antibacterial Drugs

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:Drug Industry Daily

Sponsors of systemic antibacterial drugs should evaluate their products against test panels of relevant bacteria and against approved drugs with similar mechanisms of activity, the FDA said, in a newly…

Continue ReadingFDA Publishes Guidance on Microbiology Data for Antibacterial Drugs

Macfarlan Smith Cited for GMP Deficiencies

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:Drug Industry Daily

API manufacturer Macfarlan Smith drew a Form 483 from the FDA for failing to ensure products manufactured at its Edinburgh, Scotland facility met current good manufacturing practice requirements. Source: Drug…

Continue ReadingMacfarlan Smith Cited for GMP Deficiencies

Health Groups Say Right-to-Try Could Do ‘More Harm than Good’

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:Drug Industry Daily

A group of non-profits and activist organizations, including the American Lung Association, National Health Council and National Organization for Rare Disorders, urged lawmakers in the House of Representatives not to…

Continue ReadingHealth Groups Say Right-to-Try Could Do ‘More Harm than Good’

FDA Issues Considerations for Submitting Impurity Data as ANDA Approvals Drop in January

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:Drug Industry Daily

The FDA released new information for ANDA applicants on when to submit elemental impurity data, and acknowledged that new guidelines on reporting elemental impurities had slowed approvals in January. Source:…

Continue ReadingFDA Issues Considerations for Submitting Impurity Data as ANDA Approvals Drop in January

Ousted Arcturus Founder and CEO Claims He was Improperly Pushed Out by 4 Board Members

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

Joseph E. Payne was shown the door as CEO of Arcturus last week - a move that Payne is not taking lightly. Source: BioSpace

Continue ReadingOusted Arcturus Founder and CEO Claims He was Improperly Pushed Out by 4 Board Members

2 Bay Area Biotechs That Jumped While Its Peers Cratered

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

Since Friday, the stock market has been volatile, to say the least. Source: BioSpace

Continue Reading2 Bay Area Biotechs That Jumped While Its Peers Cratered

On a Roll: FDA Calls Sage's Depression Drug a Breakthrough

  • Post author:Sam
  • Post published:February 6, 2018
  • Post category:BioPharma

This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace

Continue ReadingOn a Roll: FDA Calls Sage's Depression Drug a Breakthrough
  • Go to the previous page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 26
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company